{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:22:34Z","timestamp":1756902154342,"version":"3.44.0"},"reference-count":21,"publisher":"The Pediatric Pharmacy Association","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Chylous effusion and chylous ascites are rare but serious conditions that affect both fetuses and neonates. Previous studies have documented chylous effusions or chylous ascites treatment with medications as an adjunct to respiratory support and dietary modifications, but no formal recommendations have been made. New literature suggests propranolol as an effective and safe treatment option, though no randomized clinical studies have been published to date. This review aims to assess the efficacy and safety of propranolol in the treatment of chylous effusion and chylous ascites in fetuses and newborns from case reports.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>A comprehensive search of 10 databases and grey literature was completed. The inclusion criteria for articles were age at diagnosis less than 40 days old and case report\/series. Articles were excluded if they were animal studies or not published in English.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, 4 articles were ultimately included in the study for a total of 10 reported cases. Propranolol administered to mother and neonates was effective in 100% of cases. The most common oral dose for mothers was 20 mg, 4 times daily, titrated to 40 mg, 4 times daily. The maximum dosage varied for administration orally to neonates, with the median being 3 mg\/kg\/day. Side effects, including bradycardia and transient hypoglycemia, were seen in 20% of the cases and resolved with dose adjustment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSION<\/jats:title>\n                  <jats:p>Propranolol is a relatively effective and safe treatment option for chylous effusion and chylous ascites that can be administered prenatally or to neonates.<\/jats:p>\n               <\/jats:sec>","DOI":"10.5863\/1551-6776-29.5.468","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T10:52:30Z","timestamp":1728903150000},"page":"468-474","source":"Crossref","is-referenced-by-count":0,"title":["Propranolol As a Treatment Option for Chylous Effusions and Chylous Ascites in Fetuses and Neonates: A Systematic Review"],"prefix":"10.5863","volume":"29","author":[{"given":"Brianna","family":"Courteau","sequence":"first","affiliation":[{"name":"Masters of Science in Physician Assistant Studies (BC, GZ, SPNO, ECN, SJR), Sacred Heart University, Fairfield, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Zarlenga","sequence":"additional","affiliation":[{"name":"Masters of Science in Physician Assistant Studies (BC, GZ, SPNO, ECN, SJR), Sacred Heart University, Fairfield, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandy P.","family":"Narciso-Owen","sequence":"additional","affiliation":[{"name":"Masters of Science in Physician Assistant Studies (BC, GZ, SPNO, ECN, SJR), Sacred Heart University, Fairfield, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric C.","family":"Nemec II","sequence":"additional","affiliation":[{"name":"Masters of Science in Physician Assistant Studies (BC, GZ, SPNO, ECN, SJR), Sacred Heart University, Fairfield, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne J.","family":"Rose","sequence":"additional","affiliation":[{"name":"Masters of Science in Physician Assistant Studies (BC, GZ, SPNO, ECN, SJR), Sacred Heart University, Fairfield, CT"},{"name":"Department of Research and Discovery (SJR), Stamford Health, Stamford, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"issue":"9","key":"2024101410522361600_i2331-348X-29-5-468-b01","doi-asserted-by":"crossref","first-page":"e245576","DOI":"10.1136\/bcr-2021-245576","article-title":"Milky pleural effusion in a neonate and approach to investigating chylothorax","volume":"14","author":"Senarathne","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"8","key":"2024101410522361600_i2331-348X-29-5-468-b02","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/jpc.13889","article-title":"Octreotide for congenital and acquired chylothorax in newborns: a systematic review","volume":"54","author":"Bellini","year":"2018","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"2024101410522361600_i2331-348X-29-5-468-b03","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000518217","article-title":"Congenital chylothorax of the newborn: a systematic analysis of published cases between 1990 and 2018","volume":"101","author":"Resch","year":"2022","journal-title":"Respiration"},{"issue":"5","key":"2024101410522361600_i2331-348X-29-5-468-b04","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.pedneo.2011.06.002","article-title":"Common etiologies of neonatal pleural effusion","volume":"52","author":"Shih","year":"2011","journal-title":"Pediatr Neonatol"},{"issue":"1","key":"2024101410522361600_i2331-348X-29-5-468-b05","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2009.08.010","article-title":"Chylothorax: aetiology, diagnosis and therapeutic options","volume":"104","author":"McGrath","year":"2010","journal-title":"Respir Med"},{"issue":"9","key":"2024101410522361600_i2331-348X-29-5-468-b06","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/apt.14284","article-title":"Review article: the diagnostic approach and current management of chylous ascites","volume":"46","author":"Lizaola","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"2024101410522361600_i2331-348X-29-5-468-b07","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s40268-018-0237-9","article-title":"Octreotide use in neonates: a case series","volume":"18","author":"Zaki","year":"2018","journal-title":"Drugs RD"},{"issue":"9","key":"2024101410522361600_i2331-348X-29-5-468-b08","doi-asserted-by":"crossref","first-page":"e235849","DOI":"10.1136\/bcr-2020-235849","article-title":"Management of large congenital chylous ascites in a preterm infant: fetal and neonatal interventions","volume":"13","author":"Sooklin","year":"2020","journal-title":"BMJ Case Rep"},{"issue":"1","key":"2024101410522361600_i2331-348X-29-5-468-b09","doi-asserted-by":"crossref","first-page":"17643","DOI":"10.1038\/s41598-023-42197-9","article-title":"Post-interventional infectious complications in percutaneous transabdominal lymphatic interventions: an observational study","volume":"13","author":"Pieper","year":"2023","journal-title":"Sci Rep"},{"issue":"4","key":"2024101410522361600_i2331-348X-29-5-468-b10","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/ccr3.1449","article-title":"Successful management of extremely high-output refractory congenital chylothorax with chemical pleurodesis using 4% povidone-iodine and propranolol: a case report","volume":"6","author":"Borcyk","year":"2018","journal-title":"Clin Case Rep"},{"issue":"2","key":"2024101410522361600_i2331-348X-29-5-468-b11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2022-058555","article-title":"Propranolol therapy for congenital chylothorax","volume":"151","author":"Handal-Orefice","year":"2023","journal-title":"Pediatrics"},{"issue":"2","key":"2024101410522361600_i2331-348X-29-5-468-b12","first-page":"155","article-title":"Propranolol for the treatment of lymphatic malformations in a neonate \u2013 a case report and review of literature","volume":"25","author":"Liviskie","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"1","key":"2024101410522361600_i2331-348X-29-5-468-b13","doi-asserted-by":"crossref","first-page":"e2020049699","DOI":"10.1542\/peds.2020-049699","article-title":"Use of propranolol in the treatment of chylous effusions in infants","volume":"148","author":"Mitchell","year":"2021","journal-title":"Pediatrics"},{"volume-title":"UpToDate","author":"Propranolol: drug information","key":"2024101410522361600_i2331-348X-29-5-468-b14"},{"issue":"14","key":"2024101410522361600_i2331-348X-29-5-468-b15","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJMc1013217","article-title":"Propranolol for intractable diffuse lymphangiomatosis","volume":"364","author":"Ozeki","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"2024101410522361600_i2331-348X-29-5-468-b16","doi-asserted-by":"crossref","first-page":"e1230","DOI":"10.1002\/cl2.1230","article-title":"PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis","volume":"18","author":"Haddaway","year":"2022","journal-title":"Campbell Syst Rev"},{"key":"2024101410522361600_i2331-348X-29-5-468-b17","unstructured":"JBI Manual for Evidence Synthesis - JBI Global Wiki\n          . Accessed February 17, 2023. https:\/\/jbi-global-wiki.refined.site\/space\/MANUAL"},{"issue":"4","key":"2024101410522361600_i2331-348X-29-5-468-b18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.siny.2017.03.005","article-title":"Congenital chylothorax","volume":"22","author":"Attar","year":"2017","journal-title":"Semin Fetal Neonatal Med"},{"volume-title":"UpToDate","author":"Octreotide: drug information","key":"2024101410522361600_i2331-348X-29-5-468-b19"},{"key":"2024101410522361600_i2331-348X-29-5-468-b20","first-page":"16","article-title":"Octreotide therapy and restricted fetal growth: pregnancy in familial hyperinsulinemic hypoglycemia","volume":"2017","author":"Geilswijk","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"1","key":"2024101410522361600_i2331-348X-29-5-468-b21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1464-410X.2010.09774.x","article-title":"Laparoscopic extended pelvic lymph node dissection during radical cystectomy: technique and clinical outcomes","volume":"108","author":"Shao","year":"2011","journal-title":"BJU Int"}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/29\/5\/468\/3441619\/i2331-348x-29-5-468.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/29\/5\/468\/3441619\/i2331-348x-29-5-468.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T18:41:42Z","timestamp":1738780902000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/29\/5\/article-p468.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,10,14]]},"published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-29.5.468","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"type":"electronic","value":"2331-348X"},{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}